T. Ohtsu

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma

Kensei Tobinai, Yukio Kobayashi, Masaru Narabayashi et al. · Annals of Oncology · 1998 · 151 citations · Full text

B-cell Lymphoma, Lymphoid Neoplasia, Hematological Malignancy +7

Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

T. Ohtsu, Yosuke Sasaki, Tomohiro Tamura et al. · PubMed · 1995 · 144 citations

Peripheral Neuropathy, 24-Hour Infusion, Pharmacokinetic Modeling +13

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Tomofumi Igarashi, Yukio Kobayashi, Michinori Ogura et al. · Annals of Oncology · 2002 · 138 citations · Full text

Hematological Malignancy, Indolent B-cell Lymphoma, Progression-free Survival +10

The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study

T. Ohtsu, Atsushi Takagi, Naomi Uemura et al. · Digestion · 2017 · 76 citations · Full text

Effect of Ingested Culture of Propionibacterium freudenreichii ET-3 on Fecal Microflora and Stool Frequency in Healthy Females

Kenichi Hojo, Nobuo Yoda, Hiroshi Tsuchita et al. · Bioscience and Microflora · 2002 · 64 citations · Full text

Nutrition, Dysbiosis, Stool Frequency +16